nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—CYP2D6—Fingolimod—multiple sclerosis	0.0654	0.121	CbGbCtD
Trazodone—ABCB1—Methylprednisolone—multiple sclerosis	0.0447	0.083	CbGbCtD
Trazodone—CYP3A4—Fingolimod—multiple sclerosis	0.0416	0.0772	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0347	0.0643	CbGbCtD
Trazodone—CYP3A7—Dexamethasone—multiple sclerosis	0.0347	0.0643	CbGbCtD
Trazodone—ABCB1—Mitoxantrone—multiple sclerosis	0.0326	0.0606	CbGbCtD
Trazodone—ABCB1—Betamethasone—multiple sclerosis	0.0291	0.054	CbGbCtD
Trazodone—ABCB1—Prednisolone—multiple sclerosis	0.0287	0.0533	CbGbCtD
Trazodone—ABCB1—Prednisone—multiple sclerosis	0.0271	0.0503	CbGbCtD
Trazodone—CYP3A4—Methylprednisolone—multiple sclerosis	0.0268	0.0498	CbGbCtD
Trazodone—CYP3A5—Dexamethasone—multiple sclerosis	0.026	0.0483	CbGbCtD
Trazodone—CYP3A4—Triamcinolone—multiple sclerosis	0.0203	0.0377	CbGbCtD
Trazodone—HTR2A—trigeminal nucleus—multiple sclerosis	0.0198	0.244	CbGeAlD
Trazodone—CYP3A4—Mitoxantrone—multiple sclerosis	0.0196	0.0363	CbGbCtD
Trazodone—CYP3A4—Betamethasone—multiple sclerosis	0.0174	0.0323	CbGbCtD
Trazodone—CYP3A4—Prednisolone—multiple sclerosis	0.0172	0.0319	CbGbCtD
Trazodone—ABCB1—Dexamethasone—multiple sclerosis	0.0169	0.0314	CbGbCtD
Trazodone—CYP3A4—Prednisone—multiple sclerosis	0.0162	0.0301	CbGbCtD
Trazodone—CYP2D6—Dexamethasone—multiple sclerosis	0.0159	0.0296	CbGbCtD
Trazodone—ABCB1—Methotrexate—multiple sclerosis	0.0136	0.0252	CbGbCtD
Trazodone—CYP3A4—Dexamethasone—multiple sclerosis	0.0101	0.0188	CbGbCtD
Trazodone—HTR2A—trigeminal nerve—multiple sclerosis	0.0052	0.064	CbGeAlD
Trazodone—HTR2A—pons—multiple sclerosis	0.00366	0.0451	CbGeAlD
Trazodone—ADRA2A—peripheral nervous system—multiple sclerosis	0.00287	0.0353	CbGeAlD
Trazodone—HTR2A—pineal body—multiple sclerosis	0.00261	0.0322	CbGeAlD
Trazodone—HTR2A—peripheral nervous system—multiple sclerosis	0.00244	0.03	CbGeAlD
Trazodone—HTR2A—nerve—multiple sclerosis	0.0019	0.0234	CbGeAlD
Trazodone—HTR2C—brainstem—multiple sclerosis	0.00163	0.02	CbGeAlD
Trazodone—SLC6A4—brainstem—multiple sclerosis	0.00154	0.019	CbGeAlD
Trazodone—HTR1A—brainstem—multiple sclerosis	0.00137	0.0168	CbGeAlD
Trazodone—ADRA1A—brainstem—multiple sclerosis	0.00126	0.0155	CbGeAlD
Trazodone—HTR2C—medulla oblongata—multiple sclerosis	0.00113	0.0139	CbGeAlD
Trazodone—ORM1—spinal cord—multiple sclerosis	0.00112	0.0138	CbGeAlD
Trazodone—HTR2C—midbrain—multiple sclerosis	0.00104	0.0127	CbGeAlD
Trazodone—HTR2C—spinal cord—multiple sclerosis	0.00101	0.0124	CbGeAlD
Trazodone—SLC6A4—midbrain—multiple sclerosis	0.000982	0.0121	CbGeAlD
Trazodone—SLC6A4—spinal cord—multiple sclerosis	0.000958	0.0118	CbGeAlD
Trazodone—ORM1—nervous system—multiple sclerosis	0.000948	0.0117	CbGeAlD
Trazodone—ORM1—central nervous system—multiple sclerosis	0.000912	0.0112	CbGeAlD
Trazodone—HTR1A—midbrain—multiple sclerosis	0.000872	0.0107	CbGeAlD
Trazodone—HTR2C—nervous system—multiple sclerosis	0.000852	0.0105	CbGeAlD
Trazodone—HTR1A—spinal cord—multiple sclerosis	0.000851	0.0105	CbGeAlD
Trazodone—HTR2C—central nervous system—multiple sclerosis	0.00082	0.0101	CbGeAlD
Trazodone—HTR2A—brainstem—multiple sclerosis	0.000815	0.01	CbGeAlD
Trazodone—SLC6A4—nervous system—multiple sclerosis	0.000807	0.00993	CbGeAlD
Trazodone—HTR2B—nervous system—multiple sclerosis	0.0008	0.00984	CbGeAlD
Trazodone—HTR2A—retina—multiple sclerosis	0.000787	0.00968	CbGeAlD
Trazodone—SLC6A4—central nervous system—multiple sclerosis	0.000777	0.00956	CbGeAlD
Trazodone—HTR2B—central nervous system—multiple sclerosis	0.00077	0.00948	CbGeAlD
Trazodone—CYP2D6—brainstem—multiple sclerosis	0.000743	0.00914	CbGeAlD
Trazodone—HTR1A—nervous system—multiple sclerosis	0.000717	0.00882	CbGeAlD
Trazodone—HTR1A—central nervous system—multiple sclerosis	0.00069	0.00849	CbGeAlD
Trazodone—HTR1A—cerebellum—multiple sclerosis	0.000675	0.0083	CbGeAlD
Trazodone—ADRA2A—medulla oblongata—multiple sclerosis	0.000669	0.00823	CbGeAlD
Trazodone—ADRA1A—nervous system—multiple sclerosis	0.000661	0.00813	CbGeAlD
Trazodone—HTR2C—brain—multiple sclerosis	0.000651	0.00801	CbGeAlD
Trazodone—ADRA1A—central nervous system—multiple sclerosis	0.000636	0.00783	CbGeAlD
Trazodone—ADRA1A—cerebellum—multiple sclerosis	0.000622	0.00765	CbGeAlD
Trazodone—SLC6A4—brain—multiple sclerosis	0.000617	0.00759	CbGeAlD
Trazodone—HTR2B—brain—multiple sclerosis	0.000612	0.00752	CbGeAlD
Trazodone—ADRA2A—midbrain—multiple sclerosis	0.000611	0.00752	CbGeAlD
Trazodone—ADRA2A—spinal cord—multiple sclerosis	0.000596	0.00734	CbGeAlD
Trazodone—HTR2A—medulla oblongata—multiple sclerosis	0.000569	0.007	CbGeAlD
Trazodone—HTR1A—brain—multiple sclerosis	0.000548	0.00674	CbGeAlD
Trazodone—HTR2A—midbrain—multiple sclerosis	0.00052	0.00639	CbGeAlD
Trazodone—ABCB1—retina—multiple sclerosis	0.000516	0.00634	CbGeAlD
Trazodone—HRH1—nervous system—multiple sclerosis	0.000512	0.00629	CbGeAlD
Trazodone—HTR2A—spinal cord—multiple sclerosis	0.000507	0.00624	CbGeAlD
Trazodone—ADRA1A—brain—multiple sclerosis	0.000505	0.00621	CbGeAlD
Trazodone—ADRA2A—nervous system—multiple sclerosis	0.000502	0.00618	CbGeAlD
Trazodone—HRH1—central nervous system—multiple sclerosis	0.000493	0.00606	CbGeAlD
Trazodone—ADRA2A—central nervous system—multiple sclerosis	0.000484	0.00595	CbGeAlD
Trazodone—ADRA2A—cerebellum—multiple sclerosis	0.000473	0.00582	CbGeAlD
Trazodone—HTR2A—nervous system—multiple sclerosis	0.000427	0.00526	CbGeAlD
Trazodone—HTR2A—central nervous system—multiple sclerosis	0.000411	0.00506	CbGeAlD
Trazodone—HTR2A—cerebellum—multiple sclerosis	0.000402	0.00495	CbGeAlD
Trazodone—CYP3A4—nervous system—multiple sclerosis	0.000396	0.00487	CbGeAlD
Trazodone—HRH1—brain—multiple sclerosis	0.000391	0.00481	CbGeAlD
Trazodone—CYP2D6—nervous system—multiple sclerosis	0.000389	0.00479	CbGeAlD
Trazodone—ADRA2A—brain—multiple sclerosis	0.000384	0.00473	CbGeAlD
Trazodone—CYP3A4—central nervous system—multiple sclerosis	0.000381	0.00468	CbGeAlD
Trazodone—CYP2D6—central nervous system—multiple sclerosis	0.000375	0.00461	CbGeAlD
Trazodone—ABCB1—medulla oblongata—multiple sclerosis	0.000373	0.00458	CbGeAlD
Trazodone—CYP2D6—cerebellum—multiple sclerosis	0.000366	0.00451	CbGeAlD
Trazodone—ABCB1—midbrain—multiple sclerosis	0.000341	0.00419	CbGeAlD
Trazodone—ABCB1—spinal cord—multiple sclerosis	0.000332	0.00409	CbGeAlD
Trazodone—HTR2A—brain—multiple sclerosis	0.000327	0.00402	CbGeAlD
Trazodone—CYP2D6—brain—multiple sclerosis	0.000297	0.00366	CbGeAlD
Trazodone—ABCB1—nervous system—multiple sclerosis	0.00028	0.00344	CbGeAlD
Trazodone—ABCB1—central nervous system—multiple sclerosis	0.00027	0.00332	CbGeAlD
Trazodone—ABCB1—cerebellum—multiple sclerosis	0.000263	0.00324	CbGeAlD
Trazodone—Syncope—Methylprednisolone—multiple sclerosis	0.000243	0.000806	CcSEcCtD
Trazodone—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000242	0.000803	CcSEcCtD
Trazodone—Oedema—Prednisolone—multiple sclerosis	0.000241	0.000799	CcSEcCtD
Trazodone—Dizziness—Azathioprine—multiple sclerosis	0.000241	0.000797	CcSEcCtD
Trazodone—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000241	0.000797	CcSEcCtD
Trazodone—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000239	0.000791	CcSEcCtD
Trazodone—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000239	0.00079	CcSEcCtD
Trazodone—Shock—Prednisolone—multiple sclerosis	0.000237	0.000786	CcSEcCtD
Trazodone—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000237	0.000786	CcSEcCtD
Trazodone—Tachycardia—Prednisolone—multiple sclerosis	0.000236	0.00078	CcSEcCtD
Trazodone—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000235	0.000779	CcSEcCtD
Trazodone—Hypertension—Triamcinolone—multiple sclerosis	0.000235	0.000777	CcSEcCtD
Trazodone—Hypertension—Methylprednisolone—multiple sclerosis	0.000234	0.000776	CcSEcCtD
Trazodone—Urticaria—Mitoxantrone—multiple sclerosis	0.000234	0.000774	CcSEcCtD
Trazodone—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000233	0.000773	CcSEcCtD
Trazodone—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000233	0.00077	CcSEcCtD
Trazodone—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000233	0.00077	CcSEcCtD
Trazodone—Myalgia—Triamcinolone—multiple sclerosis	0.000232	0.000767	CcSEcCtD
Trazodone—Vomiting—Azathioprine—multiple sclerosis	0.000231	0.000766	CcSEcCtD
Trazodone—Arthralgia—Methylprednisolone—multiple sclerosis	0.000231	0.000765	CcSEcCtD
Trazodone—Myalgia—Methylprednisolone—multiple sclerosis	0.000231	0.000765	CcSEcCtD
Trazodone—Anxiety—Methylprednisolone—multiple sclerosis	0.00023	0.000762	CcSEcCtD
Trazodone—Drowsiness—Methotrexate—multiple sclerosis	0.00023	0.000761	CcSEcCtD
Trazodone—Rash—Azathioprine—multiple sclerosis	0.000229	0.00076	CcSEcCtD
Trazodone—Dermatitis—Azathioprine—multiple sclerosis	0.000229	0.000759	CcSEcCtD
Trazodone—Flushing—Prednisone—multiple sclerosis	0.000229	0.000759	CcSEcCtD
Trazodone—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000229	0.000758	CcSEcCtD
Trazodone—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000229	0.000758	CcSEcCtD
Trazodone—Discomfort—Triamcinolone—multiple sclerosis	0.000229	0.000757	CcSEcCtD
Trazodone—Discomfort—Methylprednisolone—multiple sclerosis	0.000228	0.000756	CcSEcCtD
Trazodone—Headache—Azathioprine—multiple sclerosis	0.000228	0.000755	CcSEcCtD
Trazodone—Dry mouth—Triamcinolone—multiple sclerosis	0.000226	0.00075	CcSEcCtD
Trazodone—Confusional state—Methylprednisolone—multiple sclerosis	0.000223	0.000739	CcSEcCtD
Trazodone—Malaise—Dexamethasone—multiple sclerosis	0.000223	0.000737	CcSEcCtD
Trazodone—Malaise—Betamethasone—multiple sclerosis	0.000223	0.000737	CcSEcCtD
Trazodone—Oedema—Triamcinolone—multiple sclerosis	0.000222	0.000735	CcSEcCtD
Trazodone—Vertigo—Dexamethasone—multiple sclerosis	0.000222	0.000734	CcSEcCtD
Trazodone—Vertigo—Betamethasone—multiple sclerosis	0.000222	0.000734	CcSEcCtD
Trazodone—Syncope—Dexamethasone—multiple sclerosis	0.000221	0.000733	CcSEcCtD
Trazodone—Syncope—Betamethasone—multiple sclerosis	0.000221	0.000733	CcSEcCtD
Trazodone—Arrhythmia—Prednisone—multiple sclerosis	0.000221	0.00073	CcSEcCtD
Trazodone—Sweating—Methotrexate—multiple sclerosis	0.00022	0.00073	CcSEcCtD
Trazodone—Haematuria—Methotrexate—multiple sclerosis	0.000219	0.000726	CcSEcCtD
Trazodone—Shock—Triamcinolone—multiple sclerosis	0.000218	0.000723	CcSEcCtD
Trazodone—Insomnia—Prednisolone—multiple sclerosis	0.000218	0.000723	CcSEcCtD
Trazodone—Alopecia—Prednisone—multiple sclerosis	0.000218	0.000722	CcSEcCtD
Trazodone—Shock—Methylprednisolone—multiple sclerosis	0.000218	0.000721	CcSEcCtD
Trazodone—Loss of consciousness—Betamethasone—multiple sclerosis	0.000217	0.000718	CcSEcCtD
Trazodone—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000217	0.000718	CcSEcCtD
Trazodone—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000217	0.000718	CcSEcCtD
Trazodone—Paraesthesia—Prednisolone—multiple sclerosis	0.000217	0.000718	CcSEcCtD
Trazodone—Tachycardia—Triamcinolone—multiple sclerosis	0.000217	0.000717	CcSEcCtD
Trazodone—Nausea—Azathioprine—multiple sclerosis	0.000216	0.000716	CcSEcCtD
Trazodone—Tachycardia—Methylprednisolone—multiple sclerosis	0.000216	0.000716	CcSEcCtD
Trazodone—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000215	0.00071	CcSEcCtD
Trazodone—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000214	0.000709	CcSEcCtD
Trazodone—ABCB1—brain—multiple sclerosis	0.000214	0.00263	CbGeAlD
Trazodone—Hypertension—Dexamethasone—multiple sclerosis	0.000213	0.000705	CcSEcCtD
Trazodone—Hypertension—Betamethasone—multiple sclerosis	0.000213	0.000705	CcSEcCtD
Trazodone—Asthenia—Mitoxantrone—multiple sclerosis	0.000211	0.000699	CcSEcCtD
Trazodone—Myalgia—Dexamethasone—multiple sclerosis	0.00021	0.000696	CcSEcCtD
Trazodone—Myalgia—Betamethasone—multiple sclerosis	0.00021	0.000696	CcSEcCtD
Trazodone—Anxiety—Betamethasone—multiple sclerosis	0.000209	0.000693	CcSEcCtD
Trazodone—Anxiety—Dexamethasone—multiple sclerosis	0.000209	0.000693	CcSEcCtD
Trazodone—Discomfort—Betamethasone—multiple sclerosis	0.000208	0.000687	CcSEcCtD
Trazodone—Discomfort—Dexamethasone—multiple sclerosis	0.000208	0.000687	CcSEcCtD
Trazodone—Hypotension—Methylprednisolone—multiple sclerosis	0.000207	0.000685	CcSEcCtD
Trazodone—Pain—Prednisolone—multiple sclerosis	0.000206	0.000683	CcSEcCtD
Trazodone—Vision blurred—Prednisone—multiple sclerosis	0.000203	0.000671	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000202	0.00067	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000202	0.000668	CcSEcCtD
Trazodone—Oedema—Dexamethasone—multiple sclerosis	0.000201	0.000667	CcSEcCtD
Trazodone—Oedema—Betamethasone—multiple sclerosis	0.000201	0.000667	CcSEcCtD
Trazodone—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000201	0.000667	CcSEcCtD
Trazodone—Insomnia—Triamcinolone—multiple sclerosis	0.000201	0.000665	CcSEcCtD
Trazodone—Insomnia—Methylprednisolone—multiple sclerosis	0.0002	0.000663	CcSEcCtD
Trazodone—Ill-defined disorder—Prednisone—multiple sclerosis	0.000199	0.00066	CcSEcCtD
Trazodone—Paraesthesia—Triamcinolone—multiple sclerosis	0.000199	0.00066	CcSEcCtD
Trazodone—Feeling abnormal—Prednisolone—multiple sclerosis	0.000199	0.000659	CcSEcCtD
Trazodone—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000199	0.000658	CcSEcCtD
Trazodone—Visual impairment—Methotrexate—multiple sclerosis	0.000199	0.000658	CcSEcCtD
Trazodone—Anaemia—Prednisone—multiple sclerosis	0.000199	0.000658	CcSEcCtD
Trazodone—Shock—Betamethasone—multiple sclerosis	0.000198	0.000656	CcSEcCtD
Trazodone—Shock—Dexamethasone—multiple sclerosis	0.000198	0.000656	CcSEcCtD
Trazodone—Dyspnoea—Triamcinolone—multiple sclerosis	0.000198	0.000655	CcSEcCtD
Trazodone—Agitation—Prednisone—multiple sclerosis	0.000198	0.000654	CcSEcCtD
Trazodone—Tachycardia—Dexamethasone—multiple sclerosis	0.000197	0.000651	CcSEcCtD
Trazodone—Tachycardia—Betamethasone—multiple sclerosis	0.000197	0.000651	CcSEcCtD
Trazodone—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000195	0.000645	CcSEcCtD
Trazodone—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000195	0.000645	CcSEcCtD
Trazodone—Malaise—Prednisone—multiple sclerosis	0.000194	0.000642	CcSEcCtD
Trazodone—Vertigo—Prednisone—multiple sclerosis	0.000193	0.000639	CcSEcCtD
Trazodone—Syncope—Prednisone—multiple sclerosis	0.000193	0.000638	CcSEcCtD
Trazodone—Tinnitus—Methotrexate—multiple sclerosis	0.000192	0.000637	CcSEcCtD
Trazodone—Anorexia—Dexamethasone—multiple sclerosis	0.000192	0.000636	CcSEcCtD
Trazodone—Anorexia—Betamethasone—multiple sclerosis	0.000192	0.000636	CcSEcCtD
Trazodone—Urticaria—Prednisolone—multiple sclerosis	0.000192	0.000635	CcSEcCtD
Trazodone—Fatigue—Triamcinolone—multiple sclerosis	0.000191	0.000634	CcSEcCtD
Trazodone—Fatigue—Methylprednisolone—multiple sclerosis	0.000191	0.000632	CcSEcCtD
Trazodone—Pain—Triamcinolone—multiple sclerosis	0.00019	0.000628	CcSEcCtD
Trazodone—Loss of consciousness—Prednisone—multiple sclerosis	0.000189	0.000625	CcSEcCtD
Trazodone—Hypotension—Betamethasone—multiple sclerosis	0.000188	0.000623	CcSEcCtD
Trazodone—Hypotension—Dexamethasone—multiple sclerosis	0.000188	0.000623	CcSEcCtD
Trazodone—Vomiting—Mitoxantrone—multiple sclerosis	0.000187	0.000619	CcSEcCtD
Trazodone—Hypertension—Prednisone—multiple sclerosis	0.000186	0.000614	CcSEcCtD
Trazodone—Rash—Mitoxantrone—multiple sclerosis	0.000186	0.000614	CcSEcCtD
Trazodone—Dermatitis—Mitoxantrone—multiple sclerosis	0.000185	0.000614	CcSEcCtD
Trazodone—Chills—Methotrexate—multiple sclerosis	0.000185	0.000613	CcSEcCtD
Trazodone—Headache—Mitoxantrone—multiple sclerosis	0.000184	0.00061	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000184	0.000608	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000184	0.000608	CcSEcCtD
Trazodone—Myalgia—Prednisone—multiple sclerosis	0.000183	0.000606	CcSEcCtD
Trazodone—Arthralgia—Prednisone—multiple sclerosis	0.000183	0.000606	CcSEcCtD
Trazodone—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000183	0.000606	CcSEcCtD
Trazodone—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000183	0.000604	CcSEcCtD
Trazodone—Anxiety—Prednisone—multiple sclerosis	0.000182	0.000604	CcSEcCtD
Trazodone—Alopecia—Methotrexate—multiple sclerosis	0.000182	0.000604	CcSEcCtD
Trazodone—Insomnia—Dexamethasone—multiple sclerosis	0.000182	0.000603	CcSEcCtD
Trazodone—Insomnia—Betamethasone—multiple sclerosis	0.000182	0.000603	CcSEcCtD
Trazodone—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000181	0.0006	CcSEcCtD
Trazodone—Paraesthesia—Dexamethasone—multiple sclerosis	0.000181	0.000599	CcSEcCtD
Trazodone—Paraesthesia—Betamethasone—multiple sclerosis	0.000181	0.000599	CcSEcCtD
Trazodone—Discomfort—Prednisone—multiple sclerosis	0.000181	0.000599	CcSEcCtD
Trazodone—Hypersensitivity—Prednisolone—multiple sclerosis	0.000178	0.000589	CcSEcCtD
Trazodone—Urticaria—Triamcinolone—multiple sclerosis	0.000176	0.000584	CcSEcCtD
Trazodone—Urticaria—Methylprednisolone—multiple sclerosis	0.000176	0.000583	CcSEcCtD
Trazodone—Dysgeusia—Methotrexate—multiple sclerosis	0.000176	0.000582	CcSEcCtD
Trazodone—Body temperature increased—Triamcinolone—multiple sclerosis	0.000175	0.000581	CcSEcCtD
Trazodone—Oedema—Prednisone—multiple sclerosis	0.000175	0.000581	CcSEcCtD
Trazodone—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000175	0.00058	CcSEcCtD
Trazodone—Decreased appetite—Dexamethasone—multiple sclerosis	0.000175	0.00058	CcSEcCtD
Trazodone—Decreased appetite—Betamethasone—multiple sclerosis	0.000175	0.00058	CcSEcCtD
Trazodone—Nausea—Mitoxantrone—multiple sclerosis	0.000175	0.000579	CcSEcCtD
Trazodone—Back pain—Methotrexate—multiple sclerosis	0.000174	0.000575	CcSEcCtD
Trazodone—Fatigue—Betamethasone—multiple sclerosis	0.000174	0.000575	CcSEcCtD
Trazodone—Fatigue—Dexamethasone—multiple sclerosis	0.000174	0.000575	CcSEcCtD
Trazodone—Shock—Prednisone—multiple sclerosis	0.000173	0.000571	CcSEcCtD
Trazodone—Pain—Dexamethasone—multiple sclerosis	0.000172	0.00057	CcSEcCtD
Trazodone—Pain—Betamethasone—multiple sclerosis	0.000172	0.00057	CcSEcCtD
Trazodone—Tachycardia—Prednisone—multiple sclerosis	0.000171	0.000567	CcSEcCtD
Trazodone—Hyperhidrosis—Prednisone—multiple sclerosis	0.00017	0.000561	CcSEcCtD
Trazodone—Vision blurred—Methotrexate—multiple sclerosis	0.000169	0.00056	CcSEcCtD
Trazodone—Anorexia—Prednisone—multiple sclerosis	0.000167	0.000554	CcSEcCtD
Trazodone—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000167	0.000552	CcSEcCtD
Trazodone—Anaemia—Methotrexate—multiple sclerosis	0.000166	0.00055	CcSEcCtD
Trazodone—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000166	0.00055	CcSEcCtD
Trazodone—Feeling abnormal—Betamethasone—multiple sclerosis	0.000166	0.00055	CcSEcCtD
Trazodone—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000165	0.000545	CcSEcCtD
Trazodone—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000165	0.000545	CcSEcCtD
Trazodone—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000164	0.000541	CcSEcCtD
Trazodone—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000163	0.00054	CcSEcCtD
Trazodone—Malaise—Methotrexate—multiple sclerosis	0.000162	0.000536	CcSEcCtD
Trazodone—Vertigo—Methotrexate—multiple sclerosis	0.000161	0.000534	CcSEcCtD
Trazodone—Urticaria—Dexamethasone—multiple sclerosis	0.00016	0.00053	CcSEcCtD
Trazodone—Urticaria—Betamethasone—multiple sclerosis	0.00016	0.00053	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00016	0.000529	CcSEcCtD
Trazodone—Dizziness—Prednisolone—multiple sclerosis	0.00016	0.000528	CcSEcCtD
Trazodone—Asthenia—Triamcinolone—multiple sclerosis	0.000159	0.000527	CcSEcCtD
Trazodone—Abdominal pain—Betamethasone—multiple sclerosis	0.000159	0.000527	CcSEcCtD
Trazodone—Body temperature increased—Betamethasone—multiple sclerosis	0.000159	0.000527	CcSEcCtD
Trazodone—Body temperature increased—Dexamethasone—multiple sclerosis	0.000159	0.000527	CcSEcCtD
Trazodone—Abdominal pain—Dexamethasone—multiple sclerosis	0.000159	0.000527	CcSEcCtD
Trazodone—Asthenia—Methylprednisolone—multiple sclerosis	0.000159	0.000526	CcSEcCtD
Trazodone—Insomnia—Prednisone—multiple sclerosis	0.000159	0.000525	CcSEcCtD
Trazodone—Paraesthesia—Prednisone—multiple sclerosis	0.000158	0.000521	CcSEcCtD
Trazodone—Pruritus—Triamcinolone—multiple sclerosis	0.000157	0.00052	CcSEcCtD
Trazodone—Pruritus—Methylprednisolone—multiple sclerosis	0.000157	0.000519	CcSEcCtD
Trazodone—Arthralgia—Methotrexate—multiple sclerosis	0.000153	0.000506	CcSEcCtD
Trazodone—Myalgia—Methotrexate—multiple sclerosis	0.000153	0.000506	CcSEcCtD
Trazodone—Chest pain—Methotrexate—multiple sclerosis	0.000153	0.000506	CcSEcCtD
Trazodone—Decreased appetite—Prednisone—multiple sclerosis	0.000152	0.000505	CcSEcCtD
Trazodone—Rash—Prednisolone—multiple sclerosis	0.000152	0.000504	CcSEcCtD
Trazodone—Dermatitis—Prednisolone—multiple sclerosis	0.000152	0.000503	CcSEcCtD
Trazodone—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000152	0.000502	CcSEcCtD
Trazodone—Fatigue—Prednisone—multiple sclerosis	0.000151	0.000501	CcSEcCtD
Trazodone—Headache—Prednisolone—multiple sclerosis	0.000151	0.000501	CcSEcCtD
Trazodone—Discomfort—Methotrexate—multiple sclerosis	0.000151	0.0005	CcSEcCtD
Trazodone—Constipation—Prednisone—multiple sclerosis	0.00015	0.000497	CcSEcCtD
Trazodone—Confusional state—Methotrexate—multiple sclerosis	0.000148	0.000489	CcSEcCtD
Trazodone—Dizziness—Triamcinolone—multiple sclerosis	0.000147	0.000486	CcSEcCtD
Trazodone—Dizziness—Methylprednisolone—multiple sclerosis	0.000146	0.000485	CcSEcCtD
Trazodone—Feeling abnormal—Prednisone—multiple sclerosis	0.000145	0.000479	CcSEcCtD
Trazodone—Asthenia—Betamethasone—multiple sclerosis	0.000145	0.000478	CcSEcCtD
Trazodone—Asthenia—Dexamethasone—multiple sclerosis	0.000145	0.000478	CcSEcCtD
Trazodone—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000143	0.000475	CcSEcCtD
Trazodone—Nausea—Prednisolone—multiple sclerosis	0.000143	0.000475	CcSEcCtD
Trazodone—Pruritus—Dexamethasone—multiple sclerosis	0.000142	0.000472	CcSEcCtD
Trazodone—Pruritus—Betamethasone—multiple sclerosis	0.000142	0.000472	CcSEcCtD
Trazodone—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000142	0.000469	CcSEcCtD
Trazodone—Vomiting—Triamcinolone—multiple sclerosis	0.000141	0.000467	CcSEcCtD
Trazodone—Vomiting—Methylprednisolone—multiple sclerosis	0.000141	0.000466	CcSEcCtD
Trazodone—Rash—Triamcinolone—multiple sclerosis	0.00014	0.000463	CcSEcCtD
Trazodone—Dermatitis—Triamcinolone—multiple sclerosis	0.00014	0.000463	CcSEcCtD
Trazodone—Anorexia—Methotrexate—multiple sclerosis	0.00014	0.000463	CcSEcCtD
Trazodone—Rash—Methylprednisolone—multiple sclerosis	0.00014	0.000462	CcSEcCtD
Trazodone—Dermatitis—Methylprednisolone—multiple sclerosis	0.00014	0.000462	CcSEcCtD
Trazodone—Urticaria—Prednisone—multiple sclerosis	0.000139	0.000461	CcSEcCtD
Trazodone—Headache—Triamcinolone—multiple sclerosis	0.000139	0.00046	CcSEcCtD
Trazodone—Headache—Methylprednisolone—multiple sclerosis	0.000139	0.000459	CcSEcCtD
Trazodone—Body temperature increased—Prednisone—multiple sclerosis	0.000139	0.000459	CcSEcCtD
Trazodone—Abdominal pain—Prednisone—multiple sclerosis	0.000139	0.000459	CcSEcCtD
Trazodone—Diarrhoea—Dexamethasone—multiple sclerosis	0.000138	0.000456	CcSEcCtD
Trazodone—Diarrhoea—Betamethasone—multiple sclerosis	0.000138	0.000456	CcSEcCtD
Trazodone—Hypotension—Methotrexate—multiple sclerosis	0.000137	0.000454	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000134	0.000442	CcSEcCtD
Trazodone—Dizziness—Dexamethasone—multiple sclerosis	0.000133	0.000441	CcSEcCtD
Trazodone—Dizziness—Betamethasone—multiple sclerosis	0.000133	0.000441	CcSEcCtD
Trazodone—Insomnia—Methotrexate—multiple sclerosis	0.000133	0.000439	CcSEcCtD
Trazodone—Nausea—Triamcinolone—multiple sclerosis	0.000132	0.000437	CcSEcCtD
Trazodone—Paraesthesia—Methotrexate—multiple sclerosis	0.000132	0.000436	CcSEcCtD
Trazodone—Nausea—Methylprednisolone—multiple sclerosis	0.000132	0.000436	CcSEcCtD
Trazodone—Dyspnoea—Methotrexate—multiple sclerosis	0.000131	0.000433	CcSEcCtD
Trazodone—Somnolence—Methotrexate—multiple sclerosis	0.00013	0.000431	CcSEcCtD
Trazodone—Hypersensitivity—Prednisone—multiple sclerosis	0.000129	0.000428	CcSEcCtD
Trazodone—Vomiting—Betamethasone—multiple sclerosis	0.000128	0.000424	CcSEcCtD
Trazodone—Vomiting—Dexamethasone—multiple sclerosis	0.000128	0.000424	CcSEcCtD
Trazodone—Decreased appetite—Methotrexate—multiple sclerosis	0.000127	0.000422	CcSEcCtD
Trazodone—Rash—Betamethasone—multiple sclerosis	0.000127	0.00042	CcSEcCtD
Trazodone—Rash—Dexamethasone—multiple sclerosis	0.000127	0.00042	CcSEcCtD
Trazodone—Dermatitis—Betamethasone—multiple sclerosis	0.000127	0.00042	CcSEcCtD
Trazodone—Dermatitis—Dexamethasone—multiple sclerosis	0.000127	0.00042	CcSEcCtD
Trazodone—Fatigue—Methotrexate—multiple sclerosis	0.000126	0.000418	CcSEcCtD
Trazodone—Headache—Betamethasone—multiple sclerosis	0.000126	0.000418	CcSEcCtD
Trazodone—Headache—Dexamethasone—multiple sclerosis	0.000126	0.000418	CcSEcCtD
Trazodone—Asthenia—Prednisone—multiple sclerosis	0.000126	0.000417	CcSEcCtD
Trazodone—Pain—Methotrexate—multiple sclerosis	0.000125	0.000415	CcSEcCtD
Trazodone—Pruritus—Prednisone—multiple sclerosis	0.000124	0.000411	CcSEcCtD
Trazodone—Feeling abnormal—Methotrexate—multiple sclerosis	0.000121	0.0004	CcSEcCtD
Trazodone—Diarrhoea—Prednisone—multiple sclerosis	0.00012	0.000397	CcSEcCtD
Trazodone—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.00012	0.000397	CcSEcCtD
Trazodone—Nausea—Betamethasone—multiple sclerosis	0.00012	0.000396	CcSEcCtD
Trazodone—Nausea—Dexamethasone—multiple sclerosis	0.00012	0.000396	CcSEcCtD
Trazodone—Urticaria—Methotrexate—multiple sclerosis	0.000116	0.000386	CcSEcCtD
Trazodone—Dizziness—Prednisone—multiple sclerosis	0.000116	0.000384	CcSEcCtD
Trazodone—Abdominal pain—Methotrexate—multiple sclerosis	0.000116	0.000384	CcSEcCtD
Trazodone—Body temperature increased—Methotrexate—multiple sclerosis	0.000116	0.000384	CcSEcCtD
Trazodone—Vomiting—Prednisone—multiple sclerosis	0.000112	0.000369	CcSEcCtD
Trazodone—Rash—Prednisone—multiple sclerosis	0.000111	0.000366	CcSEcCtD
Trazodone—Dermatitis—Prednisone—multiple sclerosis	0.00011	0.000366	CcSEcCtD
Trazodone—Headache—Prednisone—multiple sclerosis	0.00011	0.000364	CcSEcCtD
Trazodone—Hypersensitivity—Methotrexate—multiple sclerosis	0.000108	0.000358	CcSEcCtD
Trazodone—Asthenia—Methotrexate—multiple sclerosis	0.000105	0.000348	CcSEcCtD
Trazodone—Nausea—Prednisone—multiple sclerosis	0.000104	0.000345	CcSEcCtD
Trazodone—Pruritus—Methotrexate—multiple sclerosis	0.000104	0.000343	CcSEcCtD
Trazodone—Diarrhoea—Methotrexate—multiple sclerosis	0.0001	0.000332	CcSEcCtD
Trazodone—Dizziness—Methotrexate—multiple sclerosis	9.69e-05	0.000321	CcSEcCtD
Trazodone—Vomiting—Methotrexate—multiple sclerosis	9.32e-05	0.000309	CcSEcCtD
Trazodone—Rash—Methotrexate—multiple sclerosis	9.24e-05	0.000306	CcSEcCtD
Trazodone—Dermatitis—Methotrexate—multiple sclerosis	9.23e-05	0.000306	CcSEcCtD
Trazodone—Headache—Methotrexate—multiple sclerosis	9.18e-05	0.000304	CcSEcCtD
Trazodone—Nausea—Methotrexate—multiple sclerosis	8.71e-05	0.000288	CcSEcCtD
Trazodone—HRH1—Signaling Pathways—CCL3—multiple sclerosis	2.02e-05	0.000259	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—CCL5—multiple sclerosis	2.02e-05	0.000259	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.01e-05	0.000257	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—CCR5—multiple sclerosis	2e-05	0.000256	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—CCR5—multiple sclerosis	2e-05	0.000256	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—CCR5—multiple sclerosis	1.99e-05	0.000255	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—POMC—multiple sclerosis	1.99e-05	0.000255	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCL3—multiple sclerosis	1.98e-05	0.000254	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—TYK2—multiple sclerosis	1.98e-05	0.000254	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—POMC—multiple sclerosis	1.98e-05	0.000254	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—IL2RA—multiple sclerosis	1.97e-05	0.000253	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—IL2RA—multiple sclerosis	1.97e-05	0.000252	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—IL2RA—multiple sclerosis	1.96e-05	0.000252	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CNR1—multiple sclerosis	1.96e-05	0.000251	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—CCR5—multiple sclerosis	1.95e-05	0.000251	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PTGER4—multiple sclerosis	1.95e-05	0.00025	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CNR1—multiple sclerosis	1.95e-05	0.000249	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PTGER4—multiple sclerosis	1.94e-05	0.000249	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—BCHE—multiple sclerosis	1.94e-05	0.000249	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—IL2RA—multiple sclerosis	1.93e-05	0.000247	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PGR—multiple sclerosis	1.92e-05	0.000246	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PGR—multiple sclerosis	1.91e-05	0.000245	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PTGER4—multiple sclerosis	1.91e-05	0.000245	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.9e-05	0.000244	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.9e-05	0.000244	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CD86—multiple sclerosis	1.9e-05	0.000243	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CXCR3—multiple sclerosis	1.88e-05	0.000241	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PGR—multiple sclerosis	1.88e-05	0.000241	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CXCR3—multiple sclerosis	1.88e-05	0.000241	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CCL5—multiple sclerosis	1.87e-05	0.00024	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CD28—multiple sclerosis	1.86e-05	0.000239	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CD28—multiple sclerosis	1.86e-05	0.000238	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CXCR3—multiple sclerosis	1.84e-05	0.000236	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCL3—multiple sclerosis	1.84e-05	0.000236	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CCR2—multiple sclerosis	1.83e-05	0.000235	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—IL2—multiple sclerosis	1.83e-05	0.000234	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CCR2—multiple sclerosis	1.83e-05	0.000234	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CD28—multiple sclerosis	1.82e-05	0.000234	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—CCR5—multiple sclerosis	1.82e-05	0.000233	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—IL2—multiple sclerosis	1.81e-05	0.000233	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—POMC—multiple sclerosis	1.81e-05	0.000232	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—POMC—multiple sclerosis	1.8e-05	0.00023	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCR2—multiple sclerosis	1.79e-05	0.00023	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—IL2RA—multiple sclerosis	1.79e-05	0.00023	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.78e-05	0.000228	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PTGER4—multiple sclerosis	1.77e-05	0.000227	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—CCL2—multiple sclerosis	1.77e-05	0.000227	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CXCL10—multiple sclerosis	1.76e-05	0.000226	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—CCL2—multiple sclerosis	1.76e-05	0.000225	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CXCL10—multiple sclerosis	1.75e-05	0.000225	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PGR—multiple sclerosis	1.75e-05	0.000224	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.74e-05	0.000223	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—SPP1—multiple sclerosis	1.73e-05	0.000222	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—POMC—multiple sclerosis	1.72e-05	0.00022	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—POMC—multiple sclerosis	1.71e-05	0.00022	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CXCR3—multiple sclerosis	1.71e-05	0.000219	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CD28—multiple sclerosis	1.7e-05	0.000217	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CNR1—multiple sclerosis	1.69e-05	0.000217	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CNR1—multiple sclerosis	1.69e-05	0.000216	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CCR5—multiple sclerosis	1.68e-05	0.000216	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	1.68e-05	0.000216	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCR2—multiple sclerosis	1.67e-05	0.000214	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IL2RA—multiple sclerosis	1.66e-05	0.000213	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	1.65e-05	0.000212	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—IL2—multiple sclerosis	1.65e-05	0.000211	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—TYK2—multiple sclerosis	1.6e-05	0.000206	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—TYK2—multiple sclerosis	1.6e-05	0.000205	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—POMC—multiple sclerosis	1.56e-05	0.0002	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—POMC—multiple sclerosis	1.56e-05	0.0002	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—POMC—multiple sclerosis	1.56e-05	0.0002	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CD86—multiple sclerosis	1.54e-05	0.000197	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CNR1—multiple sclerosis	1.54e-05	0.000197	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—APOE—multiple sclerosis	1.53e-05	0.000196	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CD86—multiple sclerosis	1.53e-05	0.000196	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	1.53e-05	0.000196	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—CCL2—multiple sclerosis	1.53e-05	0.000196	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—CCL2—multiple sclerosis	1.52e-05	0.000195	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CXCL10—multiple sclerosis	1.52e-05	0.000195	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CXCL10—multiple sclerosis	1.52e-05	0.000195	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CCL5—multiple sclerosis	1.52e-05	0.000194	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CCL5—multiple sclerosis	1.51e-05	0.000193	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	1.49e-05	0.000192	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	1.49e-05	0.000191	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—APOE—multiple sclerosis	1.48e-05	0.00019	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—IL2—multiple sclerosis	1.47e-05	0.000189	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—IL2—multiple sclerosis	1.46e-05	0.000188	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.44e-05	0.000185	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—TGFB1—multiple sclerosis	1.43e-05	0.000183	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—POMC—multiple sclerosis	1.42e-05	0.000182	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—SPP1—multiple sclerosis	1.4e-05	0.00018	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—MAPK1—multiple sclerosis	1.4e-05	0.000179	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—SPP1—multiple sclerosis	1.4e-05	0.000179	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—CCL2—multiple sclerosis	1.39e-05	0.000178	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—TYK2—multiple sclerosis	1.39e-05	0.000178	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CD80—multiple sclerosis	1.38e-05	0.000178	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CXCL10—multiple sclerosis	1.38e-05	0.000177	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—TYK2—multiple sclerosis	1.38e-05	0.000177	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CCR5—multiple sclerosis	1.37e-05	0.000175	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CCR5—multiple sclerosis	1.36e-05	0.000174	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	1.36e-05	0.000174	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.35e-05	0.000173	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL2RA—multiple sclerosis	1.35e-05	0.000173	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—BCHE—multiple sclerosis	1.34e-05	0.000172	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL2RA—multiple sclerosis	1.34e-05	0.000172	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—IL2—multiple sclerosis	1.34e-05	0.000171	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CD86—multiple sclerosis	1.33e-05	0.000171	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—IL2—multiple sclerosis	1.33e-05	0.00017	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CD86—multiple sclerosis	1.33e-05	0.00017	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—POMC—multiple sclerosis	1.32e-05	0.000169	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CCL5—multiple sclerosis	1.31e-05	0.000168	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CCL5—multiple sclerosis	1.31e-05	0.000168	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	1.3e-05	0.000167	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CCL2—multiple sclerosis	1.29e-05	0.000165	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	1.28e-05	0.000164	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—POMC—multiple sclerosis	1.27e-05	0.000163	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—IL2—multiple sclerosis	1.27e-05	0.000163	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—IL2—multiple sclerosis	1.27e-05	0.000163	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.26e-05	0.000162	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	1.26e-05	0.000162	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—MAPK1—multiple sclerosis	1.26e-05	0.000162	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	1.24e-05	0.000159	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—APOE—multiple sclerosis	1.24e-05	0.000159	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—APOE—multiple sclerosis	1.24e-05	0.000158	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—SPP1—multiple sclerosis	1.21e-05	0.000155	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	1.21e-05	0.000155	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—SPP1—multiple sclerosis	1.21e-05	0.000155	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	1.19e-05	0.000153	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	1.19e-05	0.000152	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	1.18e-05	0.000151	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CCR5—multiple sclerosis	1.18e-05	0.000151	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TYK2—multiple sclerosis	1.17e-05	0.00015	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—APOE—multiple sclerosis	1.17e-05	0.00015	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	1.16e-05	0.000149	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	1.16e-05	0.000149	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—ALB—multiple sclerosis	1.16e-05	0.000149	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	1.16e-05	0.000148	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	1.15e-05	0.000148	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	1.15e-05	0.000148	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—IL2—multiple sclerosis	1.15e-05	0.000148	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	1.14e-05	0.000146	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	1.13e-05	0.000145	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CD80—multiple sclerosis	1.12e-05	0.000144	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CD80—multiple sclerosis	1.12e-05	0.000143	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	1.1e-05	0.000141	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—APOE—multiple sclerosis	1.07e-05	0.000138	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	1.07e-05	0.000138	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—APOE—multiple sclerosis	1.07e-05	0.000137	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—APOE—multiple sclerosis	1.07e-05	0.000137	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—POMC—multiple sclerosis	1.07e-05	0.000137	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—POMC—multiple sclerosis	1.06e-05	0.000136	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	1.06e-05	0.000136	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	1.05e-05	0.000135	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	1.05e-05	0.000135	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	1.04e-05	0.000134	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	1.04e-05	0.000133	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	1.02e-05	0.000131	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	1.02e-05	0.00013	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—POMC—multiple sclerosis	1e-05	0.000129	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	9.76e-06	0.000125	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IL2—multiple sclerosis	9.73e-06	0.000125	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CD80—multiple sclerosis	9.7e-06	0.000124	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CD80—multiple sclerosis	9.68e-06	0.000124	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—IL6—multiple sclerosis	9.68e-06	0.000124	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	9.5e-06	0.000122	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	9.48e-06	0.000122	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	9.43e-06	0.000121	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—POMC—multiple sclerosis	9.22e-06	0.000118	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MMP9—multiple sclerosis	9.21e-06	0.000118	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—POMC—multiple sclerosis	9.2e-06	0.000118	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—POMC—multiple sclerosis	9.19e-06	0.000118	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—ALB—multiple sclerosis	9.14e-06	0.000117	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	9.03e-06	0.000116	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	9.02e-06	0.000116	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CCL2—multiple sclerosis	9e-06	0.000115	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	8.83e-06	0.000113	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	8.83e-06	0.000113	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	8.82e-06	0.000113	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	8.8e-06	0.000113	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	8.64e-06	0.000111	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	8.39e-06	0.000108	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—ALB—multiple sclerosis	8.38e-06	0.000107	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—BCHE—multiple sclerosis	8.27e-06	0.000106	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	8.2e-06	0.000105	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	8.19e-06	0.000105	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—STAT3—multiple sclerosis	8.18e-06	0.000105	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TYK2—multiple sclerosis	8.17e-06	0.000105	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—APOE—multiple sclerosis	8.07e-06	0.000104	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	8.03e-06	0.000103	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	8.02e-06	0.000103	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL2—multiple sclerosis	7.89e-06	0.000101	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	7.85e-06	0.000101	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL2—multiple sclerosis	7.85e-06	0.000101	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	7.81e-06	0.0001	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—APOE—multiple sclerosis	7.61e-06	9.75e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MYC—multiple sclerosis	7.61e-06	9.75e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TGFB1—multiple sclerosis	7.59e-06	9.73e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	7.47e-06	9.57e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	7.45e-06	9.55e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MAPK1—multiple sclerosis	7.44e-06	9.54e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	7.43e-06	9.52e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—POMC—multiple sclerosis	6.93e-06	8.89e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL2—multiple sclerosis	6.81e-06	8.74e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL2—multiple sclerosis	6.8e-06	8.72e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	6.78e-06	8.69e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—IL6—multiple sclerosis	6.77e-06	8.68e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	6.67e-06	8.56e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	6.64e-06	8.51e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	6.64e-06	8.51e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	6.6e-06	8.47e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—POMC—multiple sclerosis	6.53e-06	8.38e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	6.45e-06	8.27e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MMP9—multiple sclerosis	6.44e-06	8.25e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—ALB—multiple sclerosis	6.32e-06	8.11e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	6.31e-06	8.1e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	6.2e-06	7.95e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	6.17e-06	7.91e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MYC—multiple sclerosis	6.17e-06	7.91e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	6.15e-06	7.89e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MYC—multiple sclerosis	6.14e-06	7.87e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	6.12e-06	7.85e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	6.03e-06	7.74e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	6e-06	7.7e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ALB—multiple sclerosis	5.96e-06	7.64e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	5.87e-06	7.52e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	5.73e-06	7.35e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—STAT3—multiple sclerosis	5.72e-06	7.34e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IL6—multiple sclerosis	5.72e-06	7.33e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	5.61e-06	7.2e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MYC—multiple sclerosis	5.33e-06	6.83e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MYC—multiple sclerosis	5.32e-06	6.82e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	5.32e-06	6.82e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	5.3e-06	6.8e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	5.22e-06	6.69e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	5.22e-06	6.69e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	5.21e-06	6.68e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	5.2e-06	6.67e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	5.2e-06	6.67e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	5.1e-06	6.54e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—APOE—multiple sclerosis	4.97e-06	6.38e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	4.85e-06	6.22e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	4.84e-06	6.2e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	4.74e-06	6.08e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL6—multiple sclerosis	4.64e-06	5.95e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL6—multiple sclerosis	4.61e-06	5.91e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—POMC—multiple sclerosis	4.27e-06	5.48e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL6—multiple sclerosis	4.01e-06	5.14e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL6—multiple sclerosis	4e-06	5.12e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	3.92e-06	5.03e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ALB—multiple sclerosis	3.9e-06	5e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	3.64e-06	4.67e-05	CbGpPWpGaD
